Literature DB >> 25477574

Importance of interdisciplinary collaboration regarding updated activated partial thromboplastin time reporting for heparin.

Sondra Davis1, Tiffany Gutierrez2, Darrell Newcomer3, Rohini C Krishnan4.   

Abstract

Entities:  

Year:  2014        PMID： 25477574      PMCID： PMC4252225          DOI： 10.1310/hpj4907-594

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  3 in total

Review 1.  Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.

Authors:  J Hirsh; S S Anand; J L Halperin; V Fuster
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

2.  AACN standards for establishing and sustaining healthy work environments: a journey to excellence.

Authors: 
Journal:  Am J Crit Care       Date:  2005-05       Impact factor: 2.228

3.  Establishing an institution-specific therapeutic range for heparin.

Authors:  D F Volles; C J Ancell; K A Michael; D M Mullins; J E Humphries
Journal:  Am J Health Syst Pharm       Date:  1998-10-01       Impact factor: 2.637
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.